{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T18:04:59Z","timestamp":1770919499091,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.vaccine.2020.03.013","type":"journal-article","created":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T08:56:52Z","timestamp":1584089812000},"page":"3422-3428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Incidence rates of health outcomes of interest among Chinese children exposed to selected vaccines in Yinzhou Electronic Health Records: A population-based retrospective cohort study"],"prefix":"10.1016","volume":"38","author":[{"given":"Kui","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sha","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingping","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bowen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3024-771X","authenticated-orcid":false,"given":"Patrick J.","family":"Arena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.03.013_b0005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2147\/CLEP.S106258","article-title":"Chinese health care system and clinical epidemiology","volume":"9","author":"Sun","year":"2017","journal-title":"Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.03.013_b0010","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1186\/s12879-018-3422-0","article-title":"The landscape of vaccine in China: history, classification, supply, and price","volume":"18","author":"Zheng","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2020.03.013_b0015","unstructured":"World Health Organization. Vaccine-preventable diseases: monitoring system, 2018 global summary, http:\/\/apps.who.int\/immunization_monitoring\/globalsummary [accessed 27 March 2019]."},{"key":"10.1016\/j.vaccine.2020.03.013_b0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12879-016-1485-3","article-title":"Streptococcus pneumoniae and Haemophilus influenzae type b carriage in Chinese children aged 12\u201318 months in Shanghai, China: a cross-sectional study","volume":"16","author":"Hu","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2020.03.013_b0025","unstructured":"http:\/\/gtoc.ningbo.gov.cn\/col\/col140\/index.html [accessed 24 May 2019]."},{"issue":"1","key":"10.1016\/j.vaccine.2020.03.013_b0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40264-017-0589-z","article-title":"Evaluation of electronic healthcare databases for post-marketing drug safety surveillance and pharmacoepidemiology in China","volume":"41","author":"Yang","year":"2018","journal-title":"Drug Saf"},{"key":"10.1016\/j.vaccine.2020.03.013_b0035","unstructured":"Global Vaccine Safety, Essential Medicine & Health Products, World Health Organization. Information sheet: observed rate of vaccine reactions: diphtheria, pertussis, tetanus vaccines. Geneva, Switzerland; 2014, https:\/\/www.who.int\/vaccine_safety\/initiative\/tools\/DTP_vaccine_rates_information_sheet.pdf [accessed 30 April 2019]."},{"issue":"3","key":"10.1016\/j.vaccine.2020.03.013_b0040","doi-asserted-by":"crossref","first-page":"235","DOI":"10.7883\/yoken.66.235","article-title":"Prospective safety monitoring of Haemophilus influenza type b and heptavalent pneumococcal conjugate vaccines in Kagoshima, Japan","volume":"66","author":"Nishi","year":"2013","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.03.013_b0045","unstructured":"Pentacel Package Insert. https:\/\/www.fda.gov\/media\/74385\/download."},{"issue":"2","key":"10.1016\/j.vaccine.2020.03.013_b0050","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jaci.2017.12.971","article-title":"Vaccine-associated hypersensitivity","volume":"141","author":"McNeil","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2020.03.013_b0055","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1016\/j.vaccine.2009.10.106","article-title":"Measles vaccine adverse events reported in the mass vaccination campaign of Sichuan province, China from 2007 to 2008","volume":"29","author":"Shu","year":"2011","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2020.03.013_b0060","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1542\/peds.112.4.815","article-title":"Risk of anaphylaxis after vaccination of children and adolescents","volume":"112","author":"Bohlke","year":"2003","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.vaccine.2020.03.013_b0065","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/SHK.0000000000000899","article-title":"Epidemiology of anaphylactic shock and its related mortality in hospital patients in Taiwan: a nationwide population-based study","volume":"48","author":"Liu","year":"2017","journal-title":"Shock"},{"issue":"2","key":"10.1016\/j.vaccine.2020.03.013_b0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.pediatrneurol.2005.08.007","article-title":"Febrile seizures in southern Chinese children: incidence and recurrence","volume":"34","author":"Chung","year":"2006","journal-title":"Pediatr Neurol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.03.013_b0075","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-0320","article-title":"Febrile seizure risk after vaccination in children 6 to 23 months","volume":"138","author":"Duffy","year":"2016","journal-title":"Pediatrics"},{"issue":"26","key":"10.1016\/j.vaccine.2020.03.013_b0080","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1016\/j.vaccine.2010.04.021","article-title":"Use of the Australian Childhood Immunisation Register for vaccine safety data linkage","volume":"28","author":"Gold","year":"2010","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2020.03.013_b0085","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1001\/jama.2012.165","article-title":"Risk of febrile seizures and epilepsy after vaccination with diphtheria, tetanus, acellular pertussis, inactivated poliovirus, and Haemophilus influenzae type B","volume":"307","author":"Sun","year":"2012","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.vaccine.2020.03.013_b0090","article-title":"The expected number of background disease events during mass immunization in China","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.vaccine.2020.03.013_b0095","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1001\/archpedi.1996.02170300011001","article-title":"The safety of acellular pertussis vaccine vs whole-cell pertussis vaccine: a postmarketing assessment","volume":"150","author":"Rosenthal","year":"1996","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"3","key":"10.1016\/j.vaccine.2020.03.013_b0100","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1542\/peds.2008-0115","article-title":"Routine vaccination against pertussis and the risk of childhood asthma: a population-based cohort study","volume":"123","author":"Spycher","year":"2009","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.vaccine.2020.03.013_b0105","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/00006454-200206000-00004","article-title":"Childhood vaccinations and risk of asthma","volume":"21","author":"DeStefano","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.03.013_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.envint.2018.02.023","article-title":"Asthma and rhinitis among Chinese children \u2013 indoor and outdoor air pollution and indicators of socioeconomic status (SES)","volume":"115","author":"Norback","year":"2018","journal-title":"Environ Int"},{"issue":"2","key":"10.1016\/j.vaccine.2020.03.013_b0115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s40272-017-0276-7","article-title":"Pediatric asthma management in China: current and future challenges","volume":"20","author":"Zhou","year":"2018","journal-title":"Paediatr Drugs"},{"issue":"2","key":"10.1016\/j.vaccine.2020.03.013_b0120","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1586\/14760584.2016.1164044","article-title":"Safety profile of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV)","volume":"16","author":"Silfverdal","year":"2017","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"10.1016\/j.vaccine.2020.03.013_b0125","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s00246-011-0121-7","article-title":"Epidemiologic survey of Kawasaki Disease in Jilin from 1999 through 2008","volume":"33","author":"Zhang","year":"2012","journal-title":"Pediatr Cardiol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.03.013_b0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/INF.0000000000000914","article-title":"Epidemiologic features of Kawasaki disease in Shanghai from 2008 through 2012","volume":"35","author":"Chen","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2020.03.013_b0135","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijid.2007.06.002","article-title":"Primary vaccination with a new heptavalent DTPw-HBV\/Hiv-Neisseria meningitides serogroups A and C combined vaccine is well tolerated","volume":"12","author":"Kerdpanich","year":"2008","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2020.03.013_b0140","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.iac.2013.09.008","article-title":"Pediatric urticaria","volume":"34","author":"Tsakok","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"issue":"6","key":"10.1016\/j.vaccine.2020.03.013_b0145","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2165\/00003495-200464060-00003","article-title":"Guillain-Barr\u00e9 syndrome: epidemiology, pathophysiology, and management","volume":"64","author":"Kuwabara","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.vaccine.2020.03.013_b0150","unstructured":"Global Vaccine Safety, Essential Medicine & Health Products, World Health Organization. Information sheet: observed rate of vaccine reactions: polio vaccines. Geneva, Switzerland. 2014, https:\/\/www.who.int\/vaccine_safety\/initiative\/tools\/polio_vaccine_rates_information_sheet.pdf [accessed 27 March 2019]."},{"issue":"1","key":"10.1016\/j.vaccine.2020.03.013_b0155","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/ene.12265","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome in parts of China: three large populations in Jiangsu province, 2008\u20132010","volume":"21","author":"Chen","year":"2014","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.vaccine.2020.03.013_b0160","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000430917","article-title":"A 15-year nationwide epidemiological analysis of Guillain- Barr\u00e9 syndrome in Taiwan","volume":"44","author":"Huang","year":"2015","journal-title":"Neuroepidemiology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20303571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20303571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:42:19Z","timestamp":1759401739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20303571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":32,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0264410X20303571"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.013","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence rates of health outcomes of interest among Chinese children exposed to selected vaccines in Yinzhou Electronic Health Records: A population-based retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}